{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:14:39Z","timestamp":1788239679255,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"DOI":"10.1007\/s40615-026-03157-x","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:51:15Z","timestamp":1788187875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reassessing the Racial Survival Disparity in Renal Medullary Carcinoma: The Roles of Race\u2013Ethnicity Misclassification and Access to Surgery"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0758-1661","authenticated-orcid":false,"given":"Guopeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengpeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangqing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"3157_CR1","doi-asserted-by":"publisher","unstructured":"Davis CJ Jr, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol. 1995;19(1):1\u201311. https:\/\/doi.org\/10.1097\/00000478-199501000-00001.","DOI":"10.1097\/00000478-199501000-00001"},{"issue":"10","key":"3157_CR2","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/pbc.25592","volume":"62","author":"O Alvarez","year":"2015","unstructured":"Alvarez O, Rodriguez MM, Jordan L, Sarnaik S. Renal medullary carcinoma and sickle cell trait: a systematic review. Pediatr Blood Cancer. 2015;62(10):1694\u20139. https:\/\/doi.org\/10.1002\/pbc.25592.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"3157_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JOP.2017.020909","volume":"13","author":"KE Beckermann","year":"2017","unstructured":"Beckermann KE, Sharma D, Chaturvedi S, Msaouel P, Abboud R, Allory Y, et al. Renal medullary carcinoma: establishing standards in practice. J Oncol Pract. 2017;13(7):414\u201321. https:\/\/doi.org\/10.1200\/JOP.2017.020909.","journal-title":"J Oncol Pract"},{"issue":"1","key":"3157_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clgc.2018.09.005","volume":"17","author":"P Msaouel","year":"2019","unstructured":"Msaouel P, Hong AL, Mullen EA, Atkins MB, Walker CL, Lee CH, et al. Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma. Clin Genitourin Cancer. 2019;17(1):1\u20136. https:\/\/doi.org\/10.1016\/j.clgc.2018.09.005.","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"3157_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/bju.13705","volume":"120","author":"AY Shah","year":"2017","unstructured":"Shah AY, Karam JA, Malouf GG, Rao P, Lim ZD, Jonasch E, et al. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study. BJU Int. 2017;120(6):782\u201392. https:\/\/doi.org\/10.1111\/bju.13705.","journal-title":"BJU Int"},{"issue":"11","key":"3157_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26609","volume":"64","author":"B Ezekian","year":"2017","unstructured":"Ezekian B, Englum B, Gilmore BF, Nag UP, Kim J, Leraas HJ, et al. Renal medullary carcinoma: a national analysis of 159 patients. Pediatr Blood Cancer. 2017;64(11):e26609. https:\/\/doi.org\/10.1002\/pbc.26609.","journal-title":"Pediatr Blood Cancer"},{"key":"3157_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jss.2023.06.019","volume":"292","author":"T Haupt","year":"2023","unstructured":"Haupt T, Akinyemi O, Raju RA, Wadley AE, Nnorom S, Aponte V, et al. Renal medullary carcinoma: a Surveillance, Epidemiology, and End Results (SEER) analysis. J Surg Res. 2023;292:1\u20136. https:\/\/doi.org\/10.1016\/j.jss.2023.06.019.","journal-title":"J Surg Res"},{"issue":"5","key":"3157_CR8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ccell.2020.04.002","volume":"37","author":"P Msaouel","year":"2020","unstructured":"Msaouel P, Malouf GG, Su X, Yao H, Tripathi DN, Soeung M, et al. Comprehensive molecular characterization identifies distinct genomic and immune hallmarks of renal medullary carcinoma. Cancer Cell. 2020;37(5):720\u2013e73413. https:\/\/doi.org\/10.1016\/j.ccell.2020.04.002.","journal-title":"Cancer Cell"},{"issue":"7","key":"3157_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1464-410X.2008.08119.x","volume":"103","author":"L Zini","year":"2009","unstructured":"Zini L, Perrotte P, Capitanio U, Jeldres C, Duclos A, Arjane P, et al. Race affects access to nephrectomy but not survival in renal cell carcinoma. BJU Int. 2009;103(7):889\u201393. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08119.x.","journal-title":"BJU Int"},{"issue":"446","key":"3157_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144.","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"3157_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786.","journal-title":"Multivar Behav Res"},{"issue":"9","key":"3157_CR12","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-17-3296","volume":"24","author":"P Msaouel","year":"2018","unstructured":"Msaouel P, Tannir NM, Walker CL. A model linking sickle cell hemoglobinopathies and SMARCB1 loss in renal medullary carcinoma. Clin Cancer Res. 2018;24(9):2044\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3296.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3157_CR13","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/j.urolonc.2012.08.011","volume":"32","author":"B Shuch","year":"2014","unstructured":"Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, et al. Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol. 2014;32(1):e239\u20132313. https:\/\/doi.org\/10.1016\/j.urolonc.2012.08.011.","journal-title":"Urol Oncol"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-026-03157-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-026-03157-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-026-03157-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:20:41Z","timestamp":1788236441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-026-03157-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":13,"alternative-id":["3157"],"URL":"https:\/\/doi.org\/10.1007\/s40615-026-03157-x","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study used publicly available, de-identified data from the Surveillance, Epidemiology and End Results (SEER) programme of the US National Cancer Institute and did not involve any direct contact with human participants. Analyses of de-identified, publicly available SEER data do not constitute human-subjects research and were exempt from institutional review board review; the study was performed in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The study used de-identified records from a public database, for which informed consent was not required.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}